l-carnitine tmao nature medicine 2013 koeth

l-carnitine tmao nature medicine 2013 koeth metaorganismal pathway and chronic inflammatory diseases γ–Butyrobetaine is a pro-atherogenic intermediate

Name: l-carnitine tmao nature medicine 2013 koeth metaorganismal pathway and chronic inflammatory diseases γ–Butyrobetaine is a pro-atherogenic intermediate
Brand: webdevsolutions.tech
SKU: 76476233979
Price: 28.82 USD
Availability: InStock
Rating: 4.2214 (24 reviews)

Butyrobetaine is a pro atherogenic intermediate in gut microbial metabolism of L carnitine to TMAO PMC Effects of choline metabolitetrimethylamine N oxide on immunometabolism in inflammatory bowel disease Frontiers A Multi omic Association Study of Trimethylamine N Oxide ScienceDirect Gut microbiota derived metabolite trimethylamine N oxide in major adverse cardiovascular events: Mechanisms, risk assessment, and therapeutic strategies

SKU: 76476233979 · From webdevsolutions.tech

4.2

USD28.82 USD57.82

Pay in 4 interest-free payments of $7.21 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 18 - Aug 23

Description

CABBI Index, p 881 Stocher T, Plattner G, Tignor M, Allen S, Boschung J, Nauel A, Xia Y, Bex V, Midgley P (2013) Climate change 2013: the physical science basis: Working Group I contribution to the Fifth assessment report of the Intergovernmental Panel on Climate Change